Active Biotech AB Cash Flow Conversion Efficiency

Latest as of June 2026: -0.242x

Active Biotech AB cash flow conversion efficiency. Based on the latest financial reports, Active Biotech AB (ACTI) has a cash flow conversion efficiency ratio of -0.242x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-9.00 Million ≈ $-968.54K USD) by net assets (Skr37.20 Million ≈ $4.00 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Active Biotech AB (2002–2025)

Cash flow conversion efficiency of Active Biotech AB from 2002 to 2025. This chart illustrates how Active Biotech AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Active Biotech AB stock price today for real-time trading data and today's change.

Active Biotech AB Cash Flow Conversion Ratio Explained

Active Biotech AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Active Biotech AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Active Biotech AB ranked by their cash flow conversion efficiency. Also see ACTI company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Netlinkz Ltd AU:NET	0.084x
Kingfish Company Nv OL:KING	-0.078x
aXichem AB ST:AXIC-A	-0.034x
Chuan Huat Resources Bhd KLSE:7016	-0.039x
NPK Co.Ltd KQ:048830	0.058x
Imugene Ltd AU:IMU	-0.620x
HANHUA FNCL HLDG CO.H YC1 F:5HF	N/A
Huize Holding Ltd NASDAQ:HUIZ	-0.197x

Annual Cash Flow Conversion Efficiency for Active Biotech AB (2002–2025)

The table below shows the annual cash flow conversion efficiency of Active Biotech AB from 2002 to 2025. Review ACTI FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr55.60 Million ≈ $5.98 Million	Skr-32.40 Million ≈ $-3.49 Million	-0.583x	+53.74%
2024-12-31	Skr32.07 Million ≈ $3.45 Million	Skr-40.40 Million ≈ $-4.35 Million	-1.260x	+15.54%
2023-12-31	Skr30.67 Million ≈ $3.30 Million	Skr-45.74 Million ≈ $-4.92 Million	-1.492x	+6.15%
2022-12-31	Skr34.51 Million ≈ $3.71 Million	Skr-54.85 Million ≈ $-5.90 Million	-1.589x	-60.68%
2021-12-31	Skr46.67 Million ≈ $5.02 Million	Skr-46.17 Million ≈ $-4.97 Million	-0.989x	+32.11%
2020-12-31	Skr22.11 Million ≈ $2.38 Million	Skr-32.22 Million ≈ $-3.47 Million	-1.457x	-118.79%
2019-12-31	Skr53.78 Million ≈ $5.79 Million	Skr-35.81 Million ≈ $-3.85 Million	-0.666x	-44.02%
2018-12-31	Skr87.92 Million ≈ $9.46 Million	Skr-40.65 Million ≈ $-4.37 Million	-0.462x	+22.68%
2017-12-31	Skr77.68 Million ≈ $8.36 Million	Skr-46.45 Million ≈ $-5.00 Million	-0.598x	-49.20%
2016-12-31	Skr182.56 Million ≈ $19.65 Million	Skr-73.16 Million ≈ $-7.87 Million	-0.401x	+66.78%
2015-12-31	Skr180.60 Million ≈ $19.44 Million	Skr-217.89 Million ≈ $-23.45 Million	-1.206x	-83.08%
2014-12-31	Skr405.31 Million ≈ $43.62 Million	Skr-267.09 Million ≈ $-28.74 Million	-0.659x	-161.28%
2013-12-31	Skr405.41 Million ≈ $43.63 Million	Skr-102.25 Million ≈ $-11.00 Million	-0.252x	+64.34%
2012-12-31	Skr339.92 Million ≈ $36.58 Million	Skr-240.40 Million ≈ $-25.87 Million	-0.707x	-655.82%
2011-12-31	Skr501.99 Million ≈ $54.02 Million	Skr-46.97 Million ≈ $-5.05 Million	-0.094x	+91.34%
2010-12-31	Skr181.76 Million ≈ $19.56 Million	Skr-196.32 Million ≈ $-21.13 Million	-1.080x	+9.35%
2009-12-31	Skr188.64 Million ≈ $20.30 Million	Skr-224.77 Million ≈ $-24.19 Million	-1.192x	-22.25%
2008-12-31	Skr163.61 Million ≈ $17.61 Million	Skr-159.46 Million ≈ $-17.16 Million	-0.975x	+1.04%
2007-12-31	Skr189.57 Million ≈ $20.40 Million	Skr-186.70 Million ≈ $-20.09 Million	-0.985x	+40.63%
2006-12-31	Skr60.36 Million ≈ $6.50 Million	Skr-100.13 Million ≈ $-10.78 Million	-1.659x	-52.37%
2005-12-31	Skr176.81 Million ≈ $19.03 Million	Skr-192.51 Million ≈ $-20.72 Million	-1.089x	-18.08%
2004-12-31	Skr162.30 Million ≈ $17.47 Million	Skr-149.65 Million ≈ $-16.10 Million	-0.922x	+7.56%
2003-12-31	Skr289.58 Million ≈ $31.16 Million	Skr-288.83 Million ≈ $-31.08 Million	-0.997x	-30.02%
2002-12-31	Skr380.27 Million ≈ $40.92 Million	Skr-291.71 Million ≈ $-31.39 Million	-0.767x	--

About Active Biotech AB

ST:ACTI Sweden Biotechnology

Market Cap

$11.63 Million

Skr108.08 Million SEK

Market Cap Rank

#26527 Global

#557 in Sweden

Share Price

Skr4.10

Change (1 day)

+2.50%

52-Week Range

Skr0.04 - Skr7.20

All Time High

Skr28.53